Development and pilot testing of two decision aids for individuals considering genetic testing for cancer risk
- PMID: 17318456
- DOI: 10.1007/s10897-006-9068-x
Development and pilot testing of two decision aids for individuals considering genetic testing for cancer risk
Abstract
Current practice in genetic counseling may not allow a full deliberation of the consequences of decisions about genetic testing for cancer risk, despite increasing demand for these services. Thus, two decision aids for individuals considering genetic testing for hereditary breast/ovarian cancer and hereditary non-polyposis colorectal cancer (HNPCC) susceptibility were developed and pilot tested with 43 individuals who had previously considered genetic testing for these cancer syndromes. A description of the decision aid development process is provided, as well as results of the pilot testing, which assessed participants' perceptions of the decision aids. All participants reported that they would recommend the decision aid to others facing the same situation, and 93% reported that the decision aid would have been relevant during their decision-making. The perceived impact of the decision aids on participants' emotions and understanding of genetic testing were assessed. Limitations of the study and future directions are discussed.
Similar articles
-
Congress report of the seventh international meeting on psychosocial aspects of genetic testing for hereditary breast and/or ovarian cancer (HBOC) and hereditary non-polyposis colorectal cancer (HNPCC).Psychooncology. 2002 Nov-Dec;11(6):536-9. doi: 10.1002/pon.629. Psychooncology. 2002. PMID: 12476435 No abstract available.
-
Development and pilot testing of a decision aid for men considering genetic testing for breast and/or ovarian cancer-related mutations (BRCA1/2).Genet Test. 2008 Dec;12(4):523-32. doi: 10.1089/gte.2008.0035. Genet Test. 2008. PMID: 19072564
-
Attitudes toward genetic testing for cancer risk after genetic counseling and decision support: a qualitative comparison between hereditary cancer types.Genet Test. 2007 Winter;11(4):401-11. doi: 10.1089/gte.2007.0013. Genet Test. 2007. PMID: 18294057
-
Information processing in the context of genetic risk: implications for genetic-risk communication.J Genet Couns. 2007 Aug;16(4):419-32. doi: 10.1007/s10897-006-9082-z. Epub 2007 May 1. J Genet Couns. 2007. PMID: 17473961 Review.
-
Psychological impact of genetic testing for cancer susceptibility: an update of the literature.Psychooncology. 2005 Dec;14(12):1060-74. doi: 10.1002/pon.933. Psychooncology. 2005. PMID: 15937976 Review.
Cited by
-
Improving women's knowledge about prenatal screening in the era of non-invasive prenatal testing for Down syndrome - development and acceptability of a low literacy decision aid.BMC Pregnancy Childbirth. 2018 Dec 17;18(1):499. doi: 10.1186/s12884-018-2135-0. BMC Pregnancy Childbirth. 2018. PMID: 30558569 Free PMC article.
-
The Risk-Reducing Effect of Aspirin in Lynch Syndrome Carriers: Development and Evaluation of an Educational Leaflet.Adv Genet (Hoboken). 2022 Mar 7;3(2):2100046. doi: 10.1002/ggn2.202100046. eCollection 2022 Jun. Adv Genet (Hoboken). 2022. PMID: 36618023 Free PMC article.
-
Evaluating a custom-designed aid to improve communication of genetic results in families with hypertrophic cardiomyopathy: study protocol for a randomised controlled trial.BMJ Open. 2019 Feb 1;9(1):e026627. doi: 10.1136/bmjopen-2018-026627. BMJ Open. 2019. PMID: 30782759 Free PMC article.
-
Family Communication and Cascade Testing for Fragile X Syndrome.J Genet Couns. 2016 Oct;25(5):1075-84. doi: 10.1007/s10897-016-9940-2. Epub 2016 Mar 9. J Genet Couns. 2016. PMID: 26961978
-
Development of Breast Cancer Choices: a decision support tool for young women with breast cancer deciding whether to have genetic testing for BRCA1/2 mutations.Support Care Cancer. 2019 Jan;27(1):297-309. doi: 10.1007/s00520-018-4307-x. Epub 2018 Jun 28. Support Care Cancer. 2019. PMID: 29955974
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical